KPL Good Food Practice AB
Uppsala, S-751 83, Sweden
NCT Number: NCT01313988
Plant sterols and fish fatty acids are known to affect the blood lipid profile. This randomized, double-blind, placebo-controlled, parallel efficacy study is designed to investigate the lipid-lowering effect after 4 weeks intervention with the recommended dose of plant sterols and different doses of fish fatty acids when combined in a spread format.
Looking for future studies?
Notify Me25 year–75 year
All sexes
Interventional
Not applicable
Uppsala, S-751 83, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
4 weeks intervention, 3 times daily
4 weeks intervention, 3 times daily
4 weeks, 3 times daily
Time frame: At baseline (after 4 weeks run-in period) and after 4 weeks intervention
Includes total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides
Time frame: At baseline (after 4 weeks run-in period) and after 4 weeks intervention
Time frame: At baseline (after 4 weeks run-in period) and after 4 weeks intervention
For exploratory purposes
Unilever R&D
Industry
Efficacy Study on the Lipid-lowering Effect of a Spread Enriched With the Recommended Dose of Plant Sterols and 3 Different Doses of Fatty Acids From Fish Oil
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02206178
Healthy
Clermont-Ferrand, France
View Trial DetailsNCT07534020
Healthy
Addison, Illinois, United States
View Trial DetailsNCT07724015
Healthy
Jaén, Spain
View Trial DetailsNCT07404254
Beverage Intake, Caffeine
San Francisco, California, United States
View Trial Details